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Background: Argentina and Uruguay are among the countries with the highest proportion of pregnant women
who smoke. The implementation of an effective smoking cessation intervention would have a significant impact on
the health of mothers and infants. The “5 A’s” (Ask, Advise, Assess, Assist, Arrange) is a strategy consisting of a brief
cessation counseling session of 5–15 minutes delivered by a trained provider. The “5 A’s” is considered the standard
of care worldwide; however, it is under used in Argentina and Uruguay.
Methods: We will conduct a two-arm, parallel cluster randomized controlled trial of an implementation
intervention in 20 prenatal care settings in Argentina and Uruguay. Prenatal care settings will be randomly allocated
to either an intervention or a control group after a baseline data collection period. Midwives’ facilitators in the 10
intervention prenatal clinics (clusters) will be identified and trained to deliver the “5 A’s” to pregnant women and
will then disseminate and implement the program. The 10 clusters in the control group will continue with their
standard in-service activities. The intervention will be tailored by formative research to be readily applicable to local
prenatal care services at maternity hospitals and acceptable to local pregnant women and health providers. Our
primary hypothesis is that the intervention is feasible in prenatal clinics in Argentina and Uruguay and will increase
the frequency of women receiving tobacco use cessation counseling during pregnancy in the intervention clinics
compared to the control clinics. Our secondary hypotheses are that the intervention will decrease the frequency of
women who smoke by the end of pregnancy, and that the intervention will increase the attitudes and readiness of
midwives towards providing counseling to women in the intervention clinics compared to the control clinics.
Trial registration: ClinicalTrials.gov. Identifier: NCT01852617
Keywords: Pregnancy, Smoking cessation, GuidelinesBackground
Tobacco use in low- and middle-income countries (LMIC)
has been increasing since 1970, while it has been stable or
decreasing in high-income countries. It is estimated that to-
bacco use currently causes 5 million deaths per year world-
wide and that it will cause 10 million deaths by the year
2020 [1]. Historically, the prevalence of smoking among
women in the developing world has been very low, mostly
because of strong cultural constraints against women
smoking; approximately 50% of men in developing nations
smoke cigarettes, compared with 9% of women [2].* Correspondence: amazzoni@iecs.org.ar
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reproduction in any medium, provided the orTobacco epidemic in women in Argentina and Uruguay
Argentina and Uruguay are among the countries with
the highest proportion of women who smoke, showing
rates of 26% to 33% in different ages and subgroups [3].
Argentina has one of the highest smoking rates in the
Americas. Reports from the National Risk Factors Sur-
vey (ENFR) conducted in 2005 [4] show that 28.6% of
women ages 18–65 were current smokers and 13.4%
were former smokers. More recent data from the 2008
National Survey of Use of Psychoactive Substances [5]
show that 30.1% of women aged 18–64 were current
smokers. Among adults, female smoking rates are still
lower than male smoking rates. [4] In Uruguay, the
smoking prevalence among women has steadilyl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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have shown that between 17.4% and 27% of women of
different age groups and locations were current smokers
[6]. The Permanent National Survey of Households in
Uruguay, which is performed annually in a random
sample of households in the whole country, and in-
cluded a question on tobacco use since 2006, showed
that 29% of women between 20–29 years old were
current smokers in that year [7]. The National Survey of
Risk Factors conducted in 2006, with a sample of 2,010
men and women ages 25–64, showed that 32.7% of the
population were current smokers. Among all women,
28.6% reported being current tobacco users, but this
proportion increased to 33% in the age group of 25–
44 years old [8]. All of the surveys also showed that
smoking prevalence was still higher in men (32% to 38%
in different groups and years) but that the difference
with women is decreasing over time. Both Argentina
and Uruguay, like other developing countries, seem to
be moving into the third stage of the tobacco-use epi-
demic, with a growing prevalence of female smokers
who will eventually exceed the prevalence in men.
Tobacco use during pregnancy in Argentina and Uruguay
Pregnant women are a priority population for tobacco
control efforts because cigarette smoking during preg-
nancy poses serious risks to fetal health. Smoking during
pregnancy may cause preterm delivery, low birth weight,
and sudden infant death syndrome [2,9]. Maternal to-
bacco use is also likely to expose infants and children to
secondhand smoke (SHS) and to provide a role model
for children’s use of tobacco [3].
There is scarce information on the prevalence of to-
bacco use during pregnancy in LMIC. Our group
conducted the only published survey in Argentina and
Uruguay designed to study pregnant women in prenatal
clinics, which was part of a global survey performed in
nine LMIC [2]. The survey, conducted during 2005 and
2006, showed that tobacco use during pregnancy is cul-
turally acceptable in these countries and found rates of
smoking during pregnancy of 10.3% in Argentina and
18.3% in Uruguay. The observed rates were lower for
other Latin American countries like Brazil (6.1%),
Ecuador (0.8%), and Guatemala (0.8%).
Reports from routinely collected data in a perinatal net-
work of 30 public maternity hospitals attending approxi-
mately 90,000 deliveries per year in the Province and City
of Buenos Aires in 2008 showed 15% of women reporting
smoking at their first prenatal visit [10]. Similar reports
from the largest public maternity hospital in Uruguay
(Hospital Pereira-Rossell), attending 9,000 childbirths per
year (15% of total births in the country), showed that
the prevalence of women smoking more than 5 ciga-
rettes per day during pregnancy was 19.5% in 2007(Internal Report, Informatic Perinatal System, personal
communication, C. Sosa).
Magri et al. reported a 33% prevalence of smoking dur-
ing all pregnancies in a survey performed of 900 women
after delivering in Hospital Pereira-Rossell [11]. Cotinine
in meconium was tested in a sample of 10% of newborns,
and positive determinations reached 51% [11].
The National Observatory of Gender and Reproduct-
ive and Sexual Health 2008 conducted a survey during
postpartum stays in a sample of 564 women who under-
went childbirth in public and private health institutions
in Uruguay. Prevalence of smoking during pregnancy
was 22% in this sample of women, and 77% reported not
receiving systematic counseling interventions from their
providers [12].
These studies suggest that Argentina and Uruguay
are among the countries with the highest smoking rates
during pregnancy in Latin America and probably
worldwide.Evidence-based interventions for smoking cessation
during pregnancy: the “5 A’s” strategy
A strong body of research supports that clinicians should
consistently identify tobacco users and provide tobacco
dependence counseling to patients who use tobacco. Brief
cessation counseling interventions based on the “5 A’s”
model (Ask, Advise, Assess, Assist, Arrange) have been
proven effective to increase smoking cessation in a wide
variety of settings, populations, and by all types of pro-
viders. The “5 A’s” strategy is currently considered the
standard of care in the United States of America for all pa-
tients contacting clinicians, including pregnant women
during prenatal care [13].
Specifically in pregnancy, randomized-controlled trials
of brief cessation strategies based on the “5 A’s” have
been summarized in several systematic reviews [13,14].
The reviews included 8 [13] to 16 studies [14] and
reported a summary risk ratio of 1.7-1.8, with 95% confi-
dence intervals (CI) of 1.3 to 2.2. These findings suggest
a 70%-80% improvement in cessation rates in women re-
ceiving brief counseling, with a 95% confidence that
there is at least a 30% improvement in cessation. The
Cochrane review [15], which classified the interventions
in a different way, found that women receiving cognitive
behavior interventions showed a 5% (95%CI 3%-8%) ab-
solute reduction in the number who continued smoking.
The intervention has been proven effective in different
ethnic groups (African Americans and non-Hispanic
whites) and has been delivered by different types of
trained health providers, including physicians, midwives,
and nurses. It is also effective among individuals with
low socioeconomic status or limited formal education
(odds ratio [OR] = 1.42; 95%CI 1.04–1.92) [13]. The “5
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women is summarized in Table 1 [14].
The evidence for brief cessation counseling in pregnancy
is based on studies conducted in high-income countries,
mainly the U.S. but also Australia and Sweden. Although
no trials were conducted in Argentina and Uruguay, there
are no serious reasons to expect that the observed effect
of the “5 A’s” intervention would not be similar in these
two countries as: 1) a large proportion of the population
of women in Argentina and Uruguay are from European
origin (Italian and Spanish immigrants) [4,16], 2) more
than 95% of women completed elementary school [4,16],
3) 99% of deliveries are attended at hospitals; more than
90% of pregnant women receive prenatal care, and 4) simi-
lar kinds of prenatal care providers are involved (physi-
cians or midwives).Tobacco control policies in Argentina and Uruguay
Strategies to promote smoking cessation in the general
population are a key component of the national tobacco
control program of the Ministry of Health in Argentina.
In 2004, a panel of experts reviewed the existing data on
smoking cessation and developed a national clinical prac-
tice guideline [17]. The recommendations included in the
clinical guidelines are very similar to the current recom-
mendations by the U.S. Department of Health and Human
Services in 2008 [13], which recommend that providers
identify all tobacco users and provide appropriate inter-
ventions if patient is willing to quit, based on the “5 A’s”
model intervention.
In Uruguay, the Ministry of Health created the National
Program for Tobacco Control in 2005 with aims to de-
crease the prevalence of tobacco use among the popula-
tion by decreasing the number of new users and by
promoting smoking cessation among current users. TheTable 1 “5 A’s” Intervention
Step 1: ASK Ask the patient about her smoking status:
A. I have NEVER smoked, or I have smoked les
B. I stopped smoking BEFORE I found out I wa
C. I stopped smoking AFTER I found out I was
D. I smoke some now, but I cut down on the
E. I smoke regularly now, about the same as B
Step 2: ADVISE Provide clear, strong advice to quit with persona
and fetus.
Step 3: ASSESS Assess the willingness of the patient to make a q
Step 4: ASSIST - Provide pregnancy-specific, self-help smoking
- Suggest and encourage the use of problem
- Arrange social support in the smoker’s enviro
- Provide social support as part of the treatme
Step 5: ARRANGE - Periodically assess smoking status and, if sheprogram also promotes the implementation of strategies
to ensure smoke-free areas in the whole country. Since
2005, the National Fund of Resources, a governmental
agency, and the National Commission on the Fight against
Cancer (an independent fund), have been implementing
workshops all over the country to train health care pro-
viders in smoking cessation skills [18]. The National
Guidelines for Tobacco Management in Uruguay include
a specific chapter for smoking cessation among pregnant
women and recommend that clinicians provide brief
counseling as the main strategy for cessation among preg-
nant women [19].
Use of the “5 A’s” intervention in pregnant women in
Argentina and Uruguay
Despite national recommendations and dissemination ef-
forts, pregnant women attending prenatal care at public
maternity hospitals and prenatal clinics are not routinely
receiving brief counseling. In 2010, we surveyed 16 public
maternity hospitals participating in a perinatal network
and four hospitals in Uruguay. Directors and coordinators
of the obstetric departments were asked if the hospital of-
fered smoking cessation programs on a routine basis to
pregnant women, what proportion of women attending
the hospital’s prenatal care clinics were screened for to-
bacco use during each prenatal visit, and what proportion
of women identified as current smokers received brief ces-
sation counseling or were referred for specialized advice.
Of the 16 hospitals, only 6 (37%) responded that they had
specific guidelines or recommendations. The median pro-
portion of women screened for tobacco use in every pre-
natal visit was 5% (range 0–100, 8 hospitals reported 0%
and 3 reported 100%), and only 10% of pregnant smokers
were receiving brief counseling.
Based on a 2005 survey of obstetrician/gynecologists
in Argentina, only 22% had received training in smokings than 100 cigarettes in my lifetime.
s pregnant, and I am not smoking now.
pregnant, and I am not smoking now.
number of cigarettes I smoke SINCE I found out I was pregnant.
EFORE I found out I was pregnant.
lized messages about the impact of smoking and quitting on the mother
uit attempt within the next 30 days.
cessation materials.
solving methods and skills for cessation.
nment.
nt.
is a continuing smoker, encourage cessation.
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knowledge to provide smoking cessation advice. Al-
though 88.9% always or almost always advised women to
stop smoking, 75% believed it was acceptable for preg-
nant women to smoke up to 6 cigarettes per day [20].
Barriers to the adoption of evidence-based practices for
tobacco cessation during pregnancy
A wide variety of barriers can hinder practitioners from
adhering to evidence-based practices. Barriers to the im-
plementation of clinical guidelines can be classified by
factors related to health providers (knowledge, attitudes
and behavior), patients, and the environment [21,22].
Regarding factors affecting the use of smoking cessation
interventions in antenatal clinics, one study conducted in
Australia investigated perceptions, knowledge, and the use
of brief interventions in midwives and physicians working
in 20 hospital antenatal clinics [23]. Results showed that
the majority of antenatal clinic staff did not use the most
effective forms of brief cessation interventions. Addition-
ally, results showed that the presence of specific proce-
dures and training in smoking cessation intervention
appeared to be the most important predictors of smoking
intervention use in those clinics.
A recently published systematic review of 23 studies
identified 10 aspects of service delivery relating to the
uptake of interventions for smoking cessation among
pregnant women. These were whether or not the subject
of smoking is broached by a health professional, the con-
tent of advice and information provided, the manner of
communication, having service protocols, follow-up dis-
cussion, staff confidence in their skills, the impact of
time and resource constraints, staff perceptions of inef-
fectiveness, differences between professionals, and obsta-
cles to accessing interventions [24].
Strategies to disseminate and implement smoking
cessation programs and clinical practice guidelines in
maternal and child health services
We have identified two trials that evaluated interven-
tions to disseminate smoking cessation programs at
antenatal clinics [25,26]. Both studies evaluated interven-
tions to actively disseminate brief intervention strategies
for smoking cessation that were recommended but not
used in antenatal clinics.
Cooke and colleagues conducted a cluster-randomized
trial in 23 hospital clinics in Australia. Clinics were ran-
domly allocated to two groups, which received the pro-
gram of brief intervention for smoking cessation either by
simple or intensive dissemination methods. Simple dissem-
ination involved materials sent by mail, and intensive dis-
semination added personal contact with trained midwives
acting as facilitators who provided support and training for
the program [25]. The outcome assessment method was atelephone interview with a manager three months after the
beginning of the program. Clinic managers were surveyed
to assess their perceptions about the program and current
use. The results showed that there were no differences in
the adoption of the program in intervention and control
clinics. Unfortunately, the outcome assessment method
used in this trial was very likely to be subject to informa-
tion bias and did not assess whether pregnant women ac-
tually received the brief intervention for smoking cessation.
Lowe and colleagues performed a cluster-randomized
trial to evaluate the impact of a behaviorally-based inter-
vention designed to increase the number of hospitals
that routinely provide effective smoking cessation pro-
grams (brief intervention) for pregnant women in 70
public hospitals in Queensland, Australia [26]. Hospitals
were randomly allocated to either a group receiving the
program in printed materials, or to a group receiving
training workshops and an implementation component
including reminders were added. The main outcome was
the rate of clinics implementing the smoking cessation
program in more than 80% of the women, assessed by
telephone interviews to the clinic medical director and
nursing director. At one year of follow-up, the results
showed that 15 (68%) of the intervention hospitals were
providing antenatal smoking cessation to smoking preg-
nant women, compared with only 3 (14%) in the control
hospitals. While the intervention was well-designed, the
outcome assessment method was likely to be susceptible
to information bias, and the actual proportion of women
receiving the program intervention was not measured.
We have not identified dissemination trials of smok-
ing cessation programs for pregnant women in Latin
American countries or in LMIC. Trials of interventions
to disseminate and implement clinical practice guide-
lines in maternal and child health in LMIC are scarce
[27], and only one has been done in Latin America,
conducted by our group. We conducted a multicenter,
international cluster randomized trial in 19 public ma-
ternity hospitals in Argentina and Uruguay [28], evalu-
ating a behavioral intervention to increase the use of
evidence-based childbirth practices.
Study hypotheses and aims
Our primary hypothesis is that an intervention designed
to motivate, persuade, and train midwives to deliver the “5
A’s” strategy during antenatal care is feasible in public pre-
natal care settings in Argentina and Uruguay and will in-
crease the frequency of women receiving tobacco use
cessation counseling during pregnancy in the intervention
clinics, compared to the standard in-service training prac-
tices at the control clinics. Our secondary hypotheses are
that the intervention will decrease the frequency of
women who smoke by the end of pregnancy, and that the
intervention will increase the attitudes and readiness of
Figure 1 Trial design.
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intervention clinics compared to the control clinics.
The main specific aim of this project is to evaluate an
intervention intended to increase the frequency of women
that receive the “5 A’s” strategy during pregnancy. In an
implementation cluster randomized-controlled trial, we
will randomize 20 prenatal care settings in the Province of
Buenos Aires, Argentina, and in Montevideo, Uruguay.
Midwife facilitators in the 10 intervention prenatal care
settings will be identified and trained on delivery of the “5
A’s” to pregnant women (training of the trainers) and on
organizing the training and delivery at their facilities in
order to reach all women in prenatal care. They will then
disseminate and implement the program in their prenatal
clinics. The intervention will be tailored by formative re-
search to be readily applicable to local prenatal care ser-
vices and to be acceptable to local pregnant women and
health providers. Pregnancy-specific self-help materials
will be adapted and their acceptability evaluated. The 10
prenatal care settings in the control group will continue
with their standard in-service activities.
Rationale for the trial
We have shown that a multifaceted intervention to imple-
ment clinical guidelines and programs is effective to in-
crease the use of childbirth practices in public maternity
hospitals in Argentina and Uruguay [28]. An intervention
following a similar basis, which includes proven, effective
strategies to disseminate guidelines or programs (interactive
workshops, training on the “5 A’s,” use of reminders), is
likely to succeed in implementing the program. Further-
more, a similar intervention was evaluated in Australia
10 years ago [25] and proved effective in increasing the
smoking cessation program implementation in prenatal
clinics, as reported by clinic managers.
Methods
Overview
We will conduct a two-arm, parallel cluster randomized-
controlled trial with baseline and follow-up cross sectional
measurements in 20 prenatal care settings in Argentina
and Uruguay. Prenatal care settings will be randomly allo-
cated to either an intervention or a control group after a
baseline data collection period. The intervention will in-
clude identification and training of midwife facilitators on
the “5 A’s.” The facilitators will then disseminate and im-
plement the smoking cessation program at their prenatal
care settings. The prenatal care settings in the control
group will continue with their standard in-service activ-
ities. A follow-up data collection period will be conducted
in all hospitals. The intervention will be tailored by forma-
tive research to be readily applicable to local prenatal care
services at busy maternity hospitals and to be acceptable
to local pregnant women and health providers (Figure 1).Participating clusters
Argentina and Uruguay are middle-income countries with a
highly literate population (97% of the population >15 years).
Approximately, 99% of the childbirths are attended at ma-
ternity hospitals; 70% and 50% of childbirths take place in
publicly-funded hospitals in Argentina and Uruguay, re-
spectively, which serve the most underprivileged population.
Prenatal care is provided by physicians and midwives, and
over 94% of pregnant women receive prenatal care during
at least four visits during pregnancy (a mean of 7 visits)
[29,30].
In the public health sector, prenatal care is offered at pre-
natal clinics within the maternity hospitals or at primary
health centers associated with them. At the hospitals, pre-
natal care providers are mostly obstetricians or obstetrical
residents assisted by midwives; while at the primary health
center, both midwives and obstetricians provide prenatal
care. Our research is intended to benefit the most under-
privileged populations in our region; as such, this study will
be conducted in a sample of prenatal clinics within public
maternity hospitals in Argentina and Uruguay and/or at
primary health centers. We will call these sites “prenatal
clinics,” irrespective of whether they are located at a hos-
pital or a primary health center.
We invited public prenatal clinics located at maternity
hospitals or primary health centers in the metropolitan
area of the Province of Buenos Aires, Argentina, and in
Montevideo, Uruguay, to participate in the study. All of
them have agreed to participate in this project. The eligi-
bility criteria for these prenatal clinics include: 1) not hav-
ing a smoking cessation program based on the “5 A’s” for
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quency of women receiving the “5 A’s” intervention below
20%, and 3) having midwives or nurse-midwives as part of
the hospital or primary health center staff.
We will collect baseline data from those pre-selected
prenatal clinics. According to the results of the analysis
of the baseline data collection, prenatal clinics will be
excluded if the frequency of women receiving the “5 A’s”
intervention is 20% or higher. Because these prenatal
clinics do not have smoking cessation program in place,
it is expected that none of them will be excluded by this
criterion. However, the sample size of the study was in-
creased to allow for exclusions.
In Argentina, prenatal care is organized in two different
settings: until 34–36 weeks of gestational age, women at-
tend their prenatal care at prenatal clinics located in pri-
mary health centers; after 34–36 weeks, they are referred
by the health center’s provider to continue prenatal care in
the maternity hospital’s prenatal clinic where they plan to
deliver. Deliveries are attended in the maternity hospitals.
In Uruguay, all prenatal care visits take place at the pre-
natal clinics located in primary health centers, and women
only go to the maternity hospitals at the time of delivery.
This different organization has implications in the con-
formation of the clusters in each country. In Argentina,
the cluster will include the prenatal clinics of the primary
health centers and the prenatal clinics of the maternity
hospitals, and in Uruguay, each prenatal clinic of a pri-
mary health center will be defined as a cluster (Figure 2).
In Argentina, we have selected 10 clusters composed
of the maternity hospitals and the associated prenatal
clinics at health centers. Each hospital has two or three
associated prenatal clinics, located in primary health
centers in the surrounding area (where women attend
prenatal care until 34–36 weeks of pregnancy). In
Uruguay, we have selected 10 prenatal clinics; each
clinic forms one cluster. All women receiving antenatal
care at the participating prenatal clinics will be eligible
to receive the “5 A’s” intervention.Figure 2 Conformation of the cluster per country. PHCs: Primary HealthRandomization procedures
The conformation of the cluster will be different in each
country. Thus, we will consider the following as a cluster:
groups of prenatal clinics, composed by the prenatal clinic
located inside the maternity hospital and the associated
prenatal clinics located in the primary health centers of the
area. Deliveries are assisted at the hospitals in both coun-
tries. Thus, the outcome will be assessed at the hospitals.
For cluster randomized trials with repeated cross-
sectional binary measurements and a limited number of
clusters, it is important to attempt to achieve as much bal-
ance as possible between the two arms of the study [31].
Based on the results of the initial assessment of health fa-
cility characteristics in the start-up phase of the study and
using the baseline data, a “balanced randomization” tech-
nique [32] will be used to better achieve balance between
the treatment groups in terms of the following characteris-
tics of the prenatal clinics: frequency of women receiving
the “5 A’s,” frequency of women who smoke during preg-
nancy, number of health providers/annual number of de-
liveries, proportion of midwives or nurse midwives who
attend prenatal care/total of providers, and country. We
have used similar randomization procedures in our re-
cently published trial of a behavioral intervention to im-
prove obstetrical care [28].
The analysis of the baseline data and the balanced
randomization procedure will be performed by the study
statistician, who will not be involved in the project man-
agement. Thus, there will be a clear separation between




Prenatal clinics allocated to the intervention group will re-
ceive an intervention divided in three phases and that will
include the following activities; 1) Awareness phase: a)
seminar to health providers and distribution of printed
materials to increase awareness of the existence of theCenters.
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midwives interested in participating as facilitators of the
program; 2) Training and persuasion phase: workshop
for training on the “5 A’s” and for planning the imple-
mentation strategy; 3) Implementation phase: imple-
mentation of the program at the prenatal clinics
identifying and training additional midwives to deliver
the “5 A’s” and using reminders for health providers and
patients. The intervention will be based on Roger’s “Dif-
fusion of Innovations” theory [33] and will be tailored
by formative research.
Theoretical basis
Roger’s “Diffusion of Innovations” theory [34] has been
previously used in trials to implement programs at prenatal
clinics, community schools, and home care associations
[26]. Diffusion is defined as the process through which an
innovation is communicated through channels over time
among members of a social system [34]. An innovation is
any idea, practice, service, or object that is considered new
by an individual or social group, such as the “5 A’s” pro-
gram. According to diffusion theory, certain characteristics
of innovations increase the chances that they will be widely
adopted. For example, the “5 A’s” program (innovation)
would be more likely to be implemented and succeed if it
is perceived as compatible with existing value systems and
lifestyles. Roger’s theory describes five phases in the diffu-
sion process: knowledge/awareness, persuasion, decision,
implementation, and confirmation. The implementation of
prenatal smoking cessation programs in prenatal clinics
may follow a similar sequence with three phases: increase
awareness about the importance and the availability of the
programs; motivate, persuade, and train health providers;
and planning and implementing the program.
We also based the intervention on two previously eval-
uated behavioral interventions based on Roger’s “Diffu-
sion of Innovations” theory:
 The multifaceted intervention to promote the use of
evidence-based childbirth practice evaluated by our
group in Argentina and Uruguay, the Guidelines
Trial [28]
 A behaviorally-based intervention designed to
increase the number of hospitals that routinely
provide effective smoking cessation programs in
Queensland, Australia [26]
Formative research
With the aim of ensuring that the intervention is effect-
ive, culturally-appropriate, and voluntarily integrated
among women and health care providers into routine
pregnancy care, formative research using qualitative and
quantitative methods was carried out during the pre-
paratory phase of the trial.Qualitative component: focus groups and in-depth
interviews
Focus groups and semi-structured interviews were con-
ducted with prenatal care providers, hospital authorities
and patients from selected public health care centers,
which provide reproductive health and prenatal care in
Buenos Aires, Argentina and Montevideo, Uruguay. The
specific aims of this component were to identify the bar-
riers and facilitators for the implementation of the “5 A’s”
intervention at prenatal clinics, to assess pregnant smo-
kers’ perspectives on adequate and readily accessible cir-
cumstances for the reception of the “5 A’s” strategy during
routine prenatal care, and to assess pregnant women’s ac-
ceptability and opinions regarding specific self-help mate-
rials to increase sustainable smoking cessation during and
after pregnancy.
Quantitative component: pilot study and preparatory survey
Pilot study We will administer a questionnaire to women
in the postpartum period admitted to six pre-selected ma-
ternity hospitals in Argentina (4 hospitals) and Uruguay (2
hospitals) where the outcomes will be measured. The ob-
jectives of the pilot study are to 1) pilot the questions to
assess the main and secondary outcomes of the trial, 2) es-
timate the proportion of women who smoke and have re-
ceived the “5 As” strategy during their prenatal care visits,
among the women who deliver at the hospital, 3) assess
agreement between saliva cotinine testing and self-
reported smoking status, and 4) evaluate the proportion of
women during postpartum hospital stay that consent to
the questionnaire and saliva cotinine testing.
We will implement 200 interviews at each hospital dur-
ing a one-month time frame (assuming refusals of
slightly over 10%). Interviews will continue until we
reach a total of 200 subjects at each hospital.
Trained interviewers, independent of the participating
prenatal clinics, will be responsible for the administra-
tion of the questionnaire. Two shifts of interviews (one
in the morning and one in the evening) will be organized
to allow for interviewing women within the first 48 hours
after delivery. The interviewers will identify all consecu-
tive women that have undergone childbirth in the past
12 hours and that have received prenatal care at any of
the participating prenatal clinics. After obtaining in-
formed consent, they will proceed with the interview.
This postpartum strategy for data collection has been
proven feasible and successful in previous studies done
by our group [35,36].
Each hospital must identify interviewers. Since the
interview is relatively brief, some sites may prefer to
have the health workers (e.g., nurses, nurse assistants)
administer the survey interview. We will train the in-
terviewers to screen, recruit, and interview the study
participants.
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ticipate and asked to sign an informed consent. Women
who agree to participate may refuse to answer any ques-
tion and can withdraw from the study at any time. The in-
formed consent will be read to the participant, her
responses will be recorded, and a signed copy of the con-
sent will be provided to the participant. Women may
agree to answer the questionnaire and/or provide a saliva
sample for cotinine test.
Preparatory survey We will conduct this survey in all
of the hospitals that will participate in the trial. The ob-
jectives of the study are: a) to estimate the number of
women in a single month attending prenatal care at par-
ticipating prenatal clinics who had their deliveries at the
maternity hospitals; and b) to evaluate the process in-
volved in a typical prenatal visit (e.g., average waiting
time, personnel involved).
Preparatory activities
To prepare the delivery of the intervention, the following
activities will be conducted:
1. Tailoring the implementation intervention:
The results of the formative research will be used
to refine the components of the intervention.
Main points that will be confirmed or redefined
will be: workshop format and length;
recommended strategies to implement the
smoking cessation program at the prenatal clinics;
type and location of reminders; and educational
materials to train health providers in the “5 A’s”
for pregnant women and pregnancy-specific self-
help materials to be provided to women within the
“5 A’s” intervention.
2. Adapting educational materials:
a. Educational materials to train health providers in
the 5 A’s.
The educational materials used in the workshops
to train health providers conducted by the
National Program of Tobacco Control in both
countries do not include specific instructions on
how to provide the “5 A’s” to pregnant women.
We adapted pregnancy-specific materials from U.
S. Agency for Healthcare Research and Quality
(AHRQ) “Treating Tobacco Use and Dependence:
Clinician's Packet. A How-To Guide For
Implementing the Public Health Service Clinical
Practice Guideline” [37] and from the UK
National Institute for Health and Clinical
Excellence’s guidelines for smoking cessation in
pregnancy [38].
b. Pregnancy-specific self-help materials to be
provided to women within the “5 A’s” intervention.Currently, pregnancy-specific self-help materials
are not provided to pregnant women by existing
cessation programs. We will adapt materials for
them from the same sources mentioned above for
health providers.3. Preparing seminars and workshops:
Contents of seminars and workshops will be defined,
agendas will be detailed, and presentations and
educational materials will be prepared and printed.
The seminar and workshop will be piloted in Buenos
Aires with a group of health providers working at
similar but not participating prenatal clinics or
maternity hospitals.
Description of the intervention
The intervention will be tailored by formative research;
therefore, the components described below could be
modified after that stage.
Awareness phase
a) Seminar to health providers and distribution of
printed materials
A seminar to all health professionals (physicians,
nurses, and midwives) will be organized at the
prenatal clinic in the hospital. The objectives of this
component will be to present prenatal care
providers with the problem of smoking during
pregnancy, national recommendations for smoking
cessation during pregnancy, the “5 A’s” intervention,
the relevance of implementing the “5 A’s”
intervention at the prenatal clinics, discuss activities
planned with the implementation intervention.
b) Identification of facilitators
We intend to identify motivated midwives working
at the prenatal clinics to serve as the facilitators who
will be trained in the cessation program and then
implement the program at their respective clinics.
There are a number of reasons to select midwives
over other types of health providers. In Argentina
and Uruguay, midwives are trained to be primary
prenatal caregivers and birth attendants. Midwives
work as prenatal care providers at prenatal clinics in
health centers. At hospitals, they mainly assist
obstetricians. Thus, they have the opportunity and
the necessary background to rapidly be trained in a
smoking cessation program targeted to pregnant
women. Women also respect the care and advice
from midwives. Midwives have been proven as
effective trained providers of the “5 A’s” in
randomized-controlled trials [15]. Although
physicians are prenatal care providers at hospitals,
they usually dedicate a very short amount time to
prenatal visits. In a study conducted in Mexico,
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spent a mean of 8–10 minutes in their physician’s
office [39]. In another study performed in a public
hospital in Buenos Aires among women receiving
prenatal care, time spent with the provider was
14 minutes [40]. However, time spent at the clinic
was longer (71–190 minutes in the four sites
described); giving ample time for midwives to
approach women for the implementation of the “5
A’s” intervention.Nevertheless, if the formative research results in the
consensus that general nurses and/or physicians can be
included as facilitators, we will adapt this protocol to
that purpose.
Facilitators will be identified by two ways after the initial
seminar: 1) self nomination: those midwives that have an
interest and are able to participate, and do not currently
smoke, will be selected; 2) those midwives nominated by
the health facilities’ authorities, and who are interested,
will be selected. No initial limit in the number of facilita-
tors will be considered. Considering the number of mid-
wives available at the health facilities, we estimate that
approximately 8–10 midwives will be selected per clinic.
Training and persuasion phase
Workshop for training on the “5 A’s” and for planning
the implementation strategy.
The facilitators will participate in a 1.5 day workshop
conducted in either Buenos Aires or Montevideo. Prenatal
clinics’ health authorities will be invited to participate or
to designate a delegate. The workshops will be given in
previously selected sites outside of the prenatal clinics and
will be conducted by a specialized trainer in smoking ces-
sation programs. Interactive workshops have been proven
an effective strategy for guidelines implementation [41].
The objectives of the workshop will be: to train facilita-
tors on the “5 A’s” intervention (training of the trainers);
to train facilitators on the suggested strategies to imple-
ment the “5 A’s” intervention program at their prenatal
clinics; and to develop a dissemination and implementa-
tion plan.
The workshop will be adapted from the current work-
shops delivered by the National Tobacco Control Pro-
grams in Argentina and Uruguay [42]. Suggested topics
to be included are: general overview of smoking preva-
lence and trend in Argentina/Uruguay; health conse-
quences of smoking during pregnancy, specifically for
the mother and the newborn baby; roles of the health
care provider in preventing smoking among pregnant
women; current recommendations and expected situ-
ation; brief explanation of smoking as an addiction;
levels of interventions to promote smoking cessation;
brief intervention “5 A’s”; assessing who is ready to quitand who is not; motivational interviews; role play; medi-
cations for smoking cessation; implementing the “5 A’s”
in the prenatal clinic. We will also ask participants to
create a plan to implement the “5 A’s.”
Implementation phase
During the implementation phase, each team of facilitators
and prenatal clinic authorities will be responsible for or-
ganizing the “5 A’s” smoking cessation program in their
prenatal clinics. The aim will be to ask all prenatal patients
their smoking status and to then offer counseling and sup-
port included in the “5 A’s” intervention to all pregnant
women who describe themselves as smokers. To this pur-
pose, we will suggest to facilitators the following strategies
to be considered in the implementation plan. First, they
should identify the health providers who will deliver the “5
A’s” to pregnant women. Second, they will train the se-
lected providers if they have not already received the train-
ing as facilitators. Finally, they will encourage use of
reminders to be displayed in the prenatal clinic waiting
rooms, clinical records, and the prenatal care.
Activities in the control group
The control group will receive no intervention after
randomization but will be asked to continue with stand-
ard in-service training activities. The control group will
receive the intervention components after the interven-
tion phase is completed.
Activities in both intervention and control groups
The overview of the study will be presented to all par-
ticipating prenatal clinics. The problem of smoking dur-
ing pregnancy and the current national guidelines will
be presented. We consider this presentation necessary to
introduce the study and ethically justified to ensure that
all providers have the same chance to know the import-
ance of the problem and current national recommenda-
tions. In a previous clinical trial, this kind of activity was




The frequency of women receiving the “5 A’s” at the end
of pregnancy (primary outcome) and the frequency of
women who smoke at the end of pregnancy (secondary
outcome) will be measured in a survey conducted within
the first 24 hours after delivery, during each woman’s
hospital stay. Additionally, tobacco status among women
who quit will be validated by cotinine analysis of saliva
submitted within the first 12 hours postpartum.
Description of questionnaire to women The survey
will be conducted using a questionnaire in paper format
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demographic data (to be extracted from the clinical rec-
ord); knowledge and attitudes regarding tobacco; to-
bacco use behaviors (specifically in the last two weeks
before delivery); secondhand smoke exposure; and to-
bacco cessation counseling received during prenatal
care. Questions on tobacco use and secondhand smoke
exposure will be based on the previously validated ques-
tionnaire to assess tobacco use during pregnancy
conducted in Argentina and Uruguay and other coun-
tries in 2005 [3,4]. Questions on tobacco cessation coun-
seling received during prenatal care will cover the five
steps of the “5 A’s” intervention: all women will be
questioned as to whether they were asked their smoking
status; smokers before pregnancy will be questioned as
to whether they were advised to quit; women who
smoked before pregnancy will also be asked if they were
assisted in their attempt to quit by receiving skills and
materials for tobacco cessation and if their counseling
was monitored at every prenatal visit.
Questionnaire administration The questionnaire was
designed for face-to-face verbal administration by
trained interviewers. Interviews will be conducted during
the hospital stay after delivery. The questionnaire will
take approximately 5–15 minutes to complete.
Cotinine analysis We will measure cotinine levels in
saliva during the immediate postpartum period, no later
than 12 hours after delivery. A witnessed sample of sal-
iva will be collected only in women that declared during
the survey that they used to smoke but that they quit at
some time during pregnancy. The sample will be col-
lected by asking women to gently chew a Salivette
sponge for 1–2 minutes until they feel it is saturated
with saliva. The sponge will be put in a collection tube
and stored for further analysis. This analysis will show if
they were exposed to nicotine during the past several
days. After the analysis is complete, the saliva sample
will be thrown away according to biosafety procedures
and will not be used for any purpose other than as previ-
ously stated. Samples will be kept in freezers and identi-
fied with the participant study number and shipped at
the end of the collection period following all biosafety
international requirements. Analysis of cotinine will be
done by the Division of Laboratory Sciences of the Cen-
ters for Disease Control and Prevention in Atlanta,
Georgia, USA, using gas chromatography and a pre-
screening with an ELISA test.
Cotinine clearance has been reported to be higher in
pregnancy, leading to a shorter half-life [43]. However,
cotinine levels increase with gestational age and are
more than twice as high at term than in the first and
second trimesters [43].Attitude and readiness to change
We will assess the attitudes and readiness to provide
counseling for smoking cessation to women (secondary
outcome) following the “5 A’s” intervention in all prenatal
care providers working at participating prenatal clinics. To
that purpose, a self-administered questionnaire will be
designed, adapted from a questionnaire developed and
used by our group to evaluate birth attendants’ readiness
to change in the Guidelines Trial [28].Process measures
Process data will be collected during the intervention
period at prenatal clinics included in the intervention
group. The objectives of this process evaluation are to: 1)
detect implementation problems that could be causal, in
case the intervention was not effective; and 2) facilitate the
replication of the intervention, in the event that it is proven
effective. Twice during the intervention period (at the mid-
way point and at the end of period), an external observer
will monitor if the smoking cessation program is
implemented and how it is organized.Data collection and management
Outcome data will be collected in two six-month periods
at all participating prenatal clusters: a baseline period and
a follow-up period, separated by the intervention phase
during which no outcome data will be collected. During
the six-month data collection periods we will collect data
on ≥200 women who have received prenatal care at each
of the participating clinics. Outcome data will be collected
in the maternity hospitals where women attending pre-
natal care at the participating prenatal clinics deliver.
Process data will be collected during the intervention
phase and only at intervention prenatal clinics.
Trained interviewers, independent of the participating
prenatal clinics, will be responsible for the administra-
tion of the questionnaire to women, including obtaining
the saliva samples. To allow for interviewing women
within the first 12 hours after deliveries, two shifts of in-
terviews will be organized: one in the morning and an-
other in the evenings. The interviewers will identify all
consecutive women who have undergone childbirth in
the past 12 hours and who have received prenatal care
at any of the participating prenatal clinics. After
obtaining informed consent, they will interview each
woman and obtain the saliva sample (if the woman is eli-
gible). Demographic and childbirth data will be extracted
from the clinical record. Cotinine samples will be kept
refrigerated and then frozen in order to keep them in
the appropriate conditions until shipment to CDC for
analysis. This postpartum strategy for data collection has
been proven feasible and successful in previous studies
of our group [35,36].
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ically for the study. A digital image of the interview form
will be taken and sent to the local data center for data
entry, but the inclusion form and the hard copy of the
interview form will remain at the hospital until the end
of the data collection period. With this system, it is en-
sured that personal identifiers will not be taken from the
hospital and will be kept securely by the hospital staff.
The data forms will be entered in each country in a se-
cure web data management system called OpenClinica,
which is an open source software for clinical research
studies using distributed data entry [44]. Digital pictures
of the data forms will be sent encrypted to the data cen-
ter by email. This system will allow for a digital backup
of all study data forms, as well as a parallel second data
entry of 10% of the forms to detect systematic errors at
data entry. This method has been successfully used in
other studies by our group.Statistical analysis
To test the primary hypothesis, we will consider the
clusters of prenatal clinics as the unit of analysis. We are
interested in observing how the absolute difference of
the percentage of women who received the 5 A’s differs
between the control and the intervention group. For that
reason, we will compute the outcome rate for each pre-
natal clinic at baseline and the follow-up periods, and
then we will calculate the outcome rate change as the
difference between the follow-up and baseline rates. We
will apply the t-test to those differences in order to test
the intervention effect. It has been demonstrated that
the t-test for two samples applied to cluster rates is ap-
propriate when the number of clusters is low [45].
For the second hypothesis, we will use the woman as
the unit of analysis because we want to study the effect
of the intervention on the individual. For that we will fit
a model in which the variables included will be the inter-
vention, the time (baseline and follow-up measures) and
the “intervention by time” interaction. To test the effect
of the intervention we will focus on the significance of
the interaction. We will use a Generalized Estimation
Equation (GEE) to estimate the model and we will report
the effect size as OR with the 95% confidence interval. For
both outcomes, we will perform an intention-to-treat ana-
lysis to compare the groups.
To test if the intervention has changed the attitudes
and readiness of midwives towards providing counseling
to women, we will consider the percentage of providers
that reported they are planning to change their approach
about tobacco with their patients in the following six
months or they have already changed it in the last six
months. We will use the same analytical approach that
will be used for the primary hypothesis.Sample size
The sample size is based on both primary and secondary
objectives. A pre-test post-test (2 time–points) nested
cross-sectional design was planned with 10 intervention
and 10 control clinics. Each intervention and control
group will contain seven clinics, with a minimum of 200
women at each time point, and three smaller clinics,
with a minimum of 120 women at each time point. For
each objective, the statistical power was estimated using
a Monte Carlo simulation with 3,000 repetitions. In the
simulation, binary outcomes from women were gener-
ated from the proposed pre-test post-test nested cross-
sectional design under the following assumptions:
 An increase in the frequency of women receiving
the “5 A’s” at the end of pregnancy from 10% to 20%
in the control group and from 10% to 50% in the
intervention group (i.e., an intervention effect of
30%) for the primary objective.
 A decrease in the frequency of women who smoke
at the end of the pregnancy from 18% to 17% in the
control group and from 18% to 12% in the
intervention group (i.e., an intervention effect of 5%)
for the secondary objective.
 An intra-cluster correlation between 2 outcomes
from different women at different times (pre-test/
post-test) = Intra-cluster correlation between 2
different women at the same time of 0.05. The value
of the latter intra-cluster correlation coefficient was
observed in a study carried out in Argentina and
Uruguay [3].
For this sample size, the estimated statistical power at
the 5% level of significance (2-sided) is 1.0 for the pri-
mary objective and 0.89 for the secondary objective.
Limitations
The cotinine analysis will allow us to prevent differential
non-disclosure of tobacco status between women who de-
clared that they quit smoking at some time during preg-
nancy in the intervention and control clinics, which can
bias the effect estimation on the smoking prevalence [46].
However, it is possible that by assessing cotinine after de-
livery, we may not detect some women smokers who had
not smoked in the last 3–4 days because of labor, delivery,
and hospital admission, who also did not self-report smok-
ing. These potential false negative results may pose a limi-
tation in correctly estimating the real prevalence of
smokers across all clinics, but will not alter the estimation
of the effect of the intervention strategy.
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